TD Waterhouse Canada’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TD Waterhouse Canada's PFE Position: Q2 2026 in Review
TD Waterhouse Canada reduced its Pfizer (PFE) stake by 0.63% in Q2 2026, selling an estimated $112K and leaving 673,108 shares worth $16.1M. The position accounts for 0.04% of the portfolio, ranked #216.
TD Waterhouse Canada first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $73.6M in Q4 2021. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- TD Waterhouse Canada held 673,108 shares of Pfizer worth $16.1M as of Q2 2026.
- TD Waterhouse Canada sold 4,290 Pfizer shares in Q2 2026, an estimated $112K.
- Pfizer made up 0.04% of TD Waterhouse Canada's portfolio in Q2 2026, its #216 holding.
- TD Waterhouse Canada first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's Pfizer position peaked at $73.6M in Q4 2021.
- 2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.